Skip to content

The Danish On-pump, Off-pump Randomization Study (DOORS)

The Impact of Avoiding Cardiopulmonary By-pass During Coronary Artery Bypass Surgery for Ischemic Heart Disease in Elderly Patients: The Danish On-pump, Off-pump Randomization Study (DOORS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00123981
Enrollment
900
Registered
2005-07-26
Start date
2005-01-31
Completion date
2011-01-31
Last updated
2013-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease

Keywords

Off-pump Coronary Artery By-pass Grafting, Randomization, stroke, myocardial infarction, mortality, graft patency, quality of life

Brief summary

Background: Coronary artery bypass grafting (CABG) can be performed either with or without the use of cardiopulmonary bypass (CPB) to obtain myocardial re-vascularisation. The investigators hypothesize that CABG without the use of CPB may reduce the risk of perioperative death, stroke, myocardial infarction and other serious complications. The aim of the present study is to compare the incidence of complications and the clinical efficacy of CABG with and without the use of CPB in elderly patients.

Detailed description

Conventional coronary artery bypass grafting (CCABG) using cardiopulmonary bypass has for decades been applied to obtain myocardial re-vascularisation and, hence, improved quality of life and survival. It does, however, bear a risk of death, stroke, myocardial infarction and other serious complications. During recent years, an equivalent operation performed on the beating heart without cardiopulmonary bypass (off-pump coronary artery bypass grafting, OPCAB) has gained popularity helped by the advent of mechanical stabilization devices and improved surgical techniques. Observational studies suggest that this technique is associated with a lower incidence of stroke, per operative arrhythmias and even mortality than conventional CCABG. This is especially the case in elderly patients and patients with significant co-morbidity. Only few randomised, controlled trials have been conducted and most of these included mainly or only low-risk, relatively young patients. These studies have documented the safety and efficacy of OPCAB compared with CCABG, but none of the trials has had the statistical strength to determine whether the rate of serious complications is lower after OPCAB operations. One recent study found graft patency to be significantly lower after OPCAB than after CCABG operations. The investigators find that there is a need of a larger scale randomised trial to compare the results of CCABG and OPCAB operations, especially in elderly patients. This patient group is poorly represented in earlier randomised trials, whereas observational studies and theoretical considerations imply that they may benefit the most from avoiding cardiopulmonary bypass. Aims: Primarily, to compare the incidence of death, stroke and myocardial infarction after CCABG and OPCAB procedures in a population of elderly patients. Furthermore, to compare quality of life and graft patency, and cost- effectiveness after CCABG and OPCAB.

Interventions

Sponsors

Kim Houlind
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age seventy years or above * Admitted for first time coronary artery bypass operation

Exclusion criteria

* Given information cannot be understood * Aortic crossclamping not safe due to calcification * Preoperative cardiac conditions demanding cardiopulmonary bypass * Re-do cardiac surgery * Patients requiring operation within the same day after conference

Design outcomes

Primary

MeasureTime frame
A combined endpoint of death + stroke + myocardial infarction within 30 days from operation30 days

Secondary

MeasureTime frame
Patency of bypass grafts assessed by coronary angiography 6 months after the operation6 months
Total mortality and cardiac mortality during follow-up3 years
A combined endpoint of death + stroke + myocardial infarction during follow-up3 years
Quality of life assessed by MOS SF-36 and EuroQol questionnaires 6 months and 3 years after the operation6 months and 3 years
Total hospital costs and costs of public care provided 6 months and 3 years after the operation and difference in costs per quality adjusted life year6 months and 3 years
Need of new intervention for cardiac angina during follow-up3 years

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026